Lyme & Tickborne Disease

 by 

Vibrant Wellness

The Tickborne Complete 1.0 detects Lyme and other tick-borne diseases through both antigen and PCR detection of microorganisms. It includes the Lyme + TBRF and Coinfections 1 panels. This is the whole blood version of the test. It is also available as a blood spot test. This test cannot be ordered for patients under 2 years of age.

 by 

Vibrant Wellness

The Tickborne 2.0 detects Lyme and other tickborne diseases through both antigen and PCR detection of microorganisms. This is the whole blood version of the test. It is also available as a blood spot test. This test cannot be ordered for patients under 2 years of age.

 by 

Vibrant Wellness

The Tickborne Complete 1.0 detects Lyme and other tick-borne diseases through both antigen and PCR detection of microorganisms. It includes the Lyme + TBRF and Coinfections 1 panels. This is the blood spot version of the test. It is also available as a whole blood test. This test cannot be ordered for patients under 2 years of age.

 by 

IGeneX

The Lyme ImmunoBlot IgG is a qualitative assay that detects IgG antibodies to B. burgdorferi strains and species. IgG antibodies are typically present a few months following initial infection.

 by 

IGeneX

The Lyme ImmunoBlot IgM is a qualitative assay that detects IgM antibodies to B. burgdorferi strains and species. The IgM ImmunoBlot may be positive as early as 1 week after a tick bite and will usually remain positive for six to eight weeks after initial exposure.

 by 

Vibrant Wellness

This panel detects Lyme disease and TBRF through both antigen and PCR detection. This is the whole blood version of the test. It is also available as a blood spot test. This test cannot be ordered for patients under 2 years of age.

 by 

IGeneX

This panel is designed to detect multiple tickborne diseases. It combines 12 tests to detect Lyme Disease, TBRF, Bartonellosis, Babesiosis, Anaplasmosis, and Ehrlichiosis.

 by 

IGeneX

The Lyme Broad Coverage Antibody (BCA) Assay is a qualitative test designed to detect IgM and IgG antibodies to Lyme Borreliae group–specific antigens in human serum. The sensitivity of the Lyme BCA Assay is 90%, and the specificity is 97%.

 by 

IGeneX

The IgG/IgM Antibody Serology test indicates the presence of both IgG and IgM antibodies to B. burgdorferi. Unlike IgM antibodies, which are present shortly after infection takes place, IgG antibodies often persist long after symptoms have disappeared. The presence of antibodies indicate exposure to Lyme–causing Borrelia, not active disease. A positive or equivocal test must be confirmed by both IgG and IgM ImmunoBlots. This test is recommended at least four weeks after exposure.

 by 

IGeneX

This test detects antibodies (IgG, IgM, IgA) against B. burgdorferi. Seroconversion usually occurs 2–3 weeks after infection and may remain elevated in cases of persistent disease. A positive or equivocal result is preliminary and should be confirmed with IgG and IgM Western Blot.